#aafth ,,congress #b;d ,session ,h4 ,r4 #baag ,,an ,,act ,to improve the health and safety of ,americans living with food allergies and related disorders1 including potentially life-threatening anaphylaxis1 food protein-induced enterocolitis syndrome1 and eosinophilic gastrointestinal diseases1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,food ,allergy ,safety1 ,treatment1 ,education1 and ,research ,act of #bjbj or the ,,faster ,act of #bjbj4 #b4 ,food allergy safety recommendations of the ,national ,academy of ,medicine 7a7 ,collection of food allergy data ,the ,public ,health ,service ,act is amended by inserting before section #cah of such ,act 7#db ,u4,s4,c4 #bdg;c7 the following new section3 #cag,w4 ,collection of food allergy data 7a7 ,in general ,the ,secretary1 acting through the ,director of the ,centers for ,disease ,control and ,prevention1 shall-- 7#a7 expand and intensify the collection of information on the prevalence of food allergies for specific allergens in the ,united ,states1 such as through the ,national ,health and ,nutrition ,examination ,survey and the ,national ,health ,interview ,survey2 7#b7 include such information within annual or other periodic reporting to the ,congress and the public on other surveillance activities2 and 7#c7 encourage research to improve the accuracy of food allergy prevalence data4 7b7 ,biomarkers ,any research conducted pursuant to subsection 7a77#c7 shall include-- 7#a7 the identification of biomarkers and tests to validate data generated from such research2 and 7#b7 the investigation of the use of identified biomarkers and tests in national surveys conducted as part of that research4 4 7b7 ,allergen labeling 7#a7 ,major food allergen definition 7,a7 ,in general ,section #bja7qq77#a7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cba7qq77#a77 is amended by striking and soybeans and inserting soybeans1 and sesame4 7,b7 ,effective date ,the amendment made by subparagraph 7,a7 shall apply with respect to food introduced or delivered for introduction into interstate commerce on or after ,january #a1 #bjbb4 7#b7 ,additional allergens ,section #bja7qq7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cba7qq77 is amended by adding at the end the following3 7#c7 ,any other food ingredient that the ,secretary determines by regulation to be a major food allergen1 based on the scientific criteria determined by the ,secretary 7including the prevalence and severity of allergic reactions to the food ingredient7 that establish that such food ingredient is an allergen of public health concern4 4 7#c7 ,technical corrections ,section #bja7qq77#b7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cba7qq77#b77 is amended by striking paragraph each place it appears and inserting subparagraph4 #c4 ,report on use by ,,fda of patient experience data on treatments for patients with food allergies ,section #cjjd of the #bast ,century ,cures ,act 7#ba ,u4,s4,c4 #cee note7 is amended-- 7#a7 by striking ,not later than and inserting the following3 7a7 ,in general ,not later than 2 and 7#b7 by adding at the end the following3 7b7 ,treatments for patients with food allergies ,each report under subsection 7a7 shall include a synopsis of the use by the ,food and ,drug ,administration in regulatory decisionmaking of patient experience data on products with an indication for the treatment of a food allergy4 4 ,passed the ,house of ,representatives ,november #ag1 #bjbj4;,clerk4